Article Details
Retrieved on: 2023-12-14 21:25:44
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Roche's atezolizumab, in platinum-resistant ovarian cancer (PROC)," commented Pankaj Mohan, Ph.D., Founder and CEO. "Our efforts to advance our ...
Article found on: www.pharmiweb.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here